Legacy Wealth Asset Management, LLC Biogen Inc. Transaction History
Legacy Wealth Asset Management, LLC
- $324 Million
- Q2 2024
A detailed history of Legacy Wealth Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 2,090 shares of BIIB stock, worth $421,762. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,090
Previous 1,998
4.6%
Holding current value
$421,762
Previous $430,000
12.56%
% of portfolio
0.15%
Previous 0.13%
Shares
15 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.35 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.3 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.93 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.43 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.15 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $29.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...